\"Russian Research Institute of Hematology and Transfusiology\"
*- Research Institute of pediatric ortopedia, St.-Petersburg;
**- Saint-Petersburg State Pediatric Medical Academy
Brief summary
The article presents the results of the blood substitute \"POLYOXIFUMARIN\" clinical study. This plasma expander was used for blood loss treatment of children with various surgical pathologies. It was found out that POLYOXIFUMARIN infused in the dose of 10-20 ml/kg normalizes electrolytic balance and acid-base condition of an organism. The medication eliminates hypovolemia effectively. It doesn\'t cause anaphylactic or allergic reactions. POLYOXIFUMARIN is approved in pediatrics.
7. Yaickii N.A., Afanasev B.V., Barishev B.A. i dr. Dostijeniya transfyziologii v korrekcii naryshenii gomeostaza. // J. «Efferentnaya terapiya». 2004. T. 10. S. 19-25.